9 nominees · 6 ballot items.
Re-elect nine directors; approve, on a nonbinding advisory basis, the compensation of named executive officers; ratify Deloitte & Touche LLP as independent auditor and authorize the Audit and Finance Committee to set auditor remuneration; and approve Irish-law corporate authorizations to allot new shares, opt-out of statutory preemption rights, and set the treasury re-allotment price range.
By separate resolutions, re-elect nine incumbent director nominees (Mona Abutaleb Stephenson; Melissa Barra; Tracey C. Doi; T. Michael Glenn; Theodore L. Harris; Gregory E. Knight; Michael T. Speetzen; John L. Stauch; Billie I. Williamson) for one-year terms expiring at the 2027 Annual General Meeting.
A nonbinding, advisory "say-on-pay" vote to approve the compensation of Pentair’s Named Executive Officers as disclosed in the CD&A and executive compensation tables.
This proposal requests a nonbinding advisory vote (a "say-on-pay") to approve the compensation of Pentair’s Named Executive Officers as disclosed in the proxy. Management is asking shareholders to endorse its pay framework, which the Compensation Committee designs to align pay with financial and strategic objectives, reward performance, and retain senior executives. The proxy discloses that the Committee uses a Comparator Group, input from Aon Consulting, and shareholder outreach to set pay levels; it emphasizes a mix of base salary, annual incentive (MIP) tied to adjusted operating income, revenue and free cash flow, and long-term incentives (performance share units, stock options, RSUs). Notable features include a CEO long-term mix weighted heavily to performance share units (75% PSUs), a sustainability modifier of +/-10% to the annual MIP payout, and pay-for-performance adjustments informed by prior say-on-pay engagement. The Board underscores recent governance actions—expanded clawback, enhanced disclosure of sustainability oversight, and changes to equity mix—to strengthen alignment with shareholders. While advisory, the vote serves as an important governance signal and a basis for future shareholder engagement; management notes prior robust support (83.6% in 2025) and continued outreach. The Compensation Committee recommends FOR because it believes the program appropriately balances short- and long-term incentives, ties payouts to measurable financial targets and sustainability progress, and follows market practices to attract and retain talent while promoting long-term shareholder value.
Ratify the appointment of Deloitte & Touche LLP as Pentair’s independent auditor for fiscal year 2026 (nonbinding advisory) and authorize the Audit and Finance Committee to set the auditor’s remuneration (binding).
Authorize the Board to allot relevant securities up to an aggregate nominal amount of $323,205 (≈32,320,560 ordinary shares), approximately 20% of issued share capital as of March 6, 2026, for 18 months.
This management proposal seeks shareholder authority under Irish law to allow the Board to allot up to approximately 20% of Pentair’s issued ordinary share capital (nominal amount $323,205) for 18 months. The authority is a routine renewal of the Board’s power to issue shares already authorized under the Articles and is intended to preserve corporate flexibility for financing, acquisitions, share-based compensation and other corporate transactions without needing a separate shareholder vote for each issuance. Management emphasizes that this request does not increase the company’s authorized share capital, and that offers or agreements entered before expiry can be completed after the term. The proposal also notes that as an NYSE-listed company, other safeguards and disclosure obligations (NYSE and SEC rules) continue to protect shareholders against dilutive actions in certain circumstances. The limited 18-month duration and the 20% cap are customary market-standard constraints intended to balance share issuance flexibility with shareholder protections. Shareholders are being asked to grant a general, conditional authority rather than approve any specific issuance, and the Board highlights that it will exercise the authority consistent with fiduciary duties and market practice. Given the Board’s rationale—maintaining flexibility to execute strategic transactions efficiently—the Board recommends a FOR vote, while investors should assess dilutionary impact and corporate capital plans when deciding.
As a special resolution, authorize the Board to disapply statutory preemption rights to allot equity securities for cash as if Section 1022(1) did not apply, limited to an aggregate nominal value of $323,205 (≈20% of issued capital) for 18 months.
This special-resolution request asks shareholders to permit the Board to disapply statutory preemption rights that would otherwise require shares issued for cash to be first offered pro rata to existing shareholders. Management argues the opt-out—limited to roughly 20% of issued capital and expiring after 18 months—is routine under Irish practice and is necessary to enable efficient capital raises and acquisitions, avoiding procedural delays that could impede strategic transactions. The proposal clarifies that preemption does not apply to non-cash consideration or employee plans, and the requested limit mirrors the allotment authority sought in Proposal 4, ensuring consistency. From a governance perspective, the opt-out shifts discretion to the Board to issue for cash—so shareholder approval provides a time-limited mandate but does not remove fiduciary duties or market disclosure obligations under NYSE/SEC rules. The Board recommends FOR, citing market-standard practice and the need for transactional agility; the resolution requires a higher approval threshold (75%) as a special resolution. Investors weighing this proposal should consider the trade-off between strategic flexibility and potential dilution, monitor any concrete issuance proposals that follow, and assess whether the Board’s historical capital allocation and communication practices justify the opt-out. Given the customary nature of this authorization in Irish companies, management frames it as facilitative rather than expansive in intent.
As a special resolution, authorize a re-allotment price range for treasury shares of 95% (minimum) to 120% (maximum) of the 30-day average NYSE closing price (or nominal value where required for employee/director plans), expiring after 18 months.
This special-resolution asks shareholders to approve the minimum and maximum price parameters (95%–120% of a 30-day NYSE average, or nominal value where required for plan obligations) at which the company may re-allot treasury shares under Irish law for 18 months. Management frames the request as a routine renewal to support share re-issuances related to employee compensation plans and other corporate purposes consistent with the company’s buyback activities. The defined band is market-standard and provides the Board with operational flexibility to re-issue treasury shares at prices that reflect short-term market moves while protecting against extreme discounts; the nominal-value carve-out preserves the ability to satisfy employee plan requirements. Because this is a special resolution, it requires a 75% approval threshold under Irish law, and the authorization is time-limited to maintain shareholder oversight. Investors should note that re-allotment authority can affect dilution and treasury share management, but when used for employee plans and in line with repurchase programs can be neutral or accretive to shareholder value. The Board recommends FOR, emphasizing customary practice and the need to preserve administrative flexibility in managing previously repurchased shares consistent with governance and disclosure obligations.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | PRICE T ROWE ASSOCIATES INC /MD/ | 6.8% | 11,012,375 | $959M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 6.6% | 10,620,323 | $925M |
| 3 | STATE STREET CORP | 5.4% | 8,756,121 | $763M |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.7% | 7,620,191 | $664M |
| 5 | BlackRock, Inc. | 3.5% | 5,634,019 | $491M |
| 6 | Pictet Asset Management Holding SA | 2.4% | 3,906,622 | $340M |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 3,886,375 | $337M |
| 8 | BlackRock, Inc. | 2.4% | 3,810,208 | $332M |
| 9 | Invesco Ltd. | 2.3% | 3,655,703 | $318M |
| 10 | AMERIPRISE FINANCIAL INC | 1.8% | 2,833,868 | $247M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.